A biotech start-up founded by a former Google artificial intelligence expert has raised $100mn from Silicon Valley heavyweights Nvidia and Andreessen Horowitz as the market for generative AI applications expands into pharmaceuticals.
Palo Alto-based Inceptive plans to use the funds to develop new types of vaccines and drugs. It is designing “biological software” using the latest AI technology that was pioneered by the company’s founder Jakob Uszkoreit, who co-authored a paper that kick-started generative AI advances such as ChatGPT.
您已閱讀17%（686字），剩余83%（3315字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。